Ipamorelin: A Laboratory Research Reference

Ipamorelin is a synthetic peptide in the growth hormone secretagogue (GHS) family, and is classified in the literature as a ghrelin receptor agonist — a molecule that engages the same receptor activated by the endogenous hormone ghrelin. It is studied in laboratory research for its interaction with the ghrelin receptor and the downstream promotion of growth hormone release in experimental models.

This page is a non-promotional scientific reference for researchers. It does not provide performance, anti-ageing, therapeutic, or human-use guidance. Ipamorelin supplied by Bulk Aussie Peptides is for laboratory research purposes only.

What Is Ipamorelin?

Ipamorelin is a small synthetic peptide acting through the ghrelin receptor, sometimes written as the growth hormone secretagogue receptor type 1a (GHSR-1a). As a ghrelin-mimetic, it is a member of a broader family of secretagogues that stimulate growth hormone release through a receptor pathway distinct from that used by GHRH analogues.

Because it is a secretagogue rather than a GHRH analogue, ipamorelin is often investigated alongside GHRH analogues to compare the two mechanisms of growth hormone stimulation. For background on how research peptides of this type are produced and verified, see the synthetic peptides research guide.

Mechanism as Studied

In laboratory models, ipamorelin binds to the ghrelin receptor (GHSR-1a) and promotes growth hormone release through the same receptor pathway used by endogenous ghrelin. This distinguishes it from GHRH-receptor agonists such as CJC-1295, which act through a different receptor. For a side-by-side treatment of these two mechanisms, see the CJC-1295 versus ipamorelin comparison.

Molecular Characteristics

• Classification: a growth hormone secretagogue and ghrelin receptor (GHSR-1a) agonist.
• Receptor target: the ghrelin receptor, distinct from the GHRH receptor targeted by GHRH analogues.
• Molecular weight: reported in Daltons (Da) and compared against the theoretical sequence-derived mass.
• Physical form: lyophilised (freeze-dried) powder.

Areas of Scientific Research

• Ghrelin receptor pharmacology: GHSR-1a binding, activation, and downstream signalling.
• Growth hormone release: secretagogue-mediated stimulation in experimental models.
• Mechanistic comparison: secretagogue versus GHRH analogue pathways of growth hormone stimulation.

These investigations are conducted in vitro or in approved animal research models under institutional oversight.

Analytical Testing

Ipamorelin is characterised using:

• HPLC for purity assessment.
• Mass spectrometry for identity confirmation by molecular mass.

See how to read a peptide Certificate of Analysis for interpretation guidance.

References and Further Reading

• Ipamorelin and the growth hormone secretagogue family. (Preclinical research literature on ghrelin receptor agonism.)
• CJC-1295 vs Ipamorelin — a detailed comparison.
• Peptide Mass Spectrometry Testing.